2018 American Transplant Congress

Sunday, June 3, 2018

3:06pm-3:18pm

NFkB Inhibitor Improves Glycemic Control after Syngeneic Islet Transplantation by Suppression of Proinflammatory and Apoptotic Gene Expression in a Cerulein-Induced Pancreatitis Model

G. Yoshimatsu,¹ C. Darden,² K. Kumano,² C. Chang,² P. Saravanan,² M. Lawrence,² B. Naziruddin.³

Concurrent Session: Islet Cell and Cell Transplantation  •  Room 2AB

3:06pm-3:18pm

Origin and Traffic of Donor-Derived Extracellular Vesicles during Allo-Sensitization

F. Zeng,¹ W. Shufesky,¹ M. Yang,¹ Q. Liu,¹ A. Larregina,² A. Morelli.¹

Concurrent Session: Antigen Presentation / Allorecognition / Dendritic Cells  •  Room 4C-3

3:06pm-3:18pm

Renal Function, Blood Pressure, and Histologic Changes in Living Kidney Transplant Recipients from Hypertensive Donors

T. Dienemann, J. Schellenberg, K. Amann, K. Heller, A. Weidemann.

Concurrent Session: Kidney Living Donor: Selection  •  Room 606/607

3:06pm-3:18pm

Safety and Efficacy of Tocilizumab (anti-IL6R, TCZ) Therapy in the Treatment of Chronic Antibody Mediated Rejection (cABMR) in Pediatric Renal Transplant Recipients

D. Puliyanda, I. Kim, J. Choi, M. Haas, X. Zhang, A. Vo, H. Pizzo, S. Jordan.

Concurrent Session: Kidney: Pediatrics - 1  •  Room 3AB

3:06pm-3:18pm

The Role of Donor-Derived Cell-Free DNA in Identification of Injury in Kidney Allografts with Antibody-Mediated Rejection and De Novo DSA

H. Zhang,¹ L. Liu,¹ C. Zheng,² X. Li,¹ Q. Fu,¹ J. Li,¹ Q. Su,¹ H. Huang,¹ M. Ye,² C. Wang.¹

Concurrent Session: Kidney Acute Antibody Mediated Rejection  •  Room Hall 4B

3:06pm-3:18pm

Transplantation of Kidneys from Hepatitis C Virus (HCV) Antibody (Ab) Positive, NAT Negative Donors to HCV Negative Patients Results in Seroconversion but Not Viral Transmission

M. de Vera, M. Volk, Z. Ncube, A. Kore, M. Robinson, P. Wai, S. Blais, P. Baron, R. Villicana.

Concurrent Session: Kidney Infectious - Viral Hepatitis  •  Room 4C-4

3:18pm-3:30pm

Development of a Novel Assay System for Ex Vivo T-Cell Mediated Rejection Responses in Intestinal Grafts

S. Okano,^1,2 K. Abu-Elmagd,² D. Kish,¹ K. Keslar,¹ M. Fujiki,² G. Costa,² C. Miller,² W. Baldwin,¹ R. Fairchild,¹ K. Hashimoto.²

Concurrent Session: Small Bowel: All Topics  •  Room 210

3:18pm-3:30pm

Donor Deficiency of RIP3 Phosphokinase Activity Shortens Cardiac Allograft Survival in the Setting of Costimulation Blockade

M. Zhu, K. Samy, L. Lin, J. Wang, L. Cendales, A. Kirk, A. Barbas, T. Brennan.

Concurrent Session: Antigen Presentation / Allorecognition / Dendritic Cells  •  Room 4C-3

3:18pm-3:30pm

Evolving Trends in Demographic and Medical Characteristics of Liver Transplant Recipients

R. Rosenblatt,¹ N. Shen,¹ Z. Tafesh,¹ B. Fortune,¹ K. Halazun,¹ A. Jesudian.¹

Concurrent Session: Liver: Recipient Selection  •  Room 6C

3:18pm-3:30pm

Feasibility of a National Class II Matching Strategy for Pediatric Kidney Transplant Candidates

T. Blydt-Hansen,¹ W. Klement,² K. Tinckam,³ J. Gill.¹

Concurrent Session: Kidney: Pediatrics - 1  •  Room 3AB